Literature DB >> 25354895

In vitro simulation of in vivo pharmacokinetic model with intravenous administration via flow rate modulation.

Yuan-Cheng Chen1, Wang Liang, Jia-Li Hu, Gao-Li He, Xiao-Jie Wu, Xiao-Fang Liu, Jing Zhang, Xue-Qian Hu.   

Abstract

The aim of this paper was to propose a method of flow rate modulation for simulation of in vivo pharmacokinetic (PK) model with intravenous injection based on a basic in vitro PK model. According to the rule of same relative change rate of concentration per unit time in vivo and in vitro, the equations for flow rate modulation were derived using equation method. Four examples from literature were given to show the application of flow rate modulation in the simulation of PK model of antimicrobial agents in vitro. Then an experiment was performed to confirm the feasibility of flow rate modulation method using levo-ornidazole as an example. The accuracy and precision of PK simulations were evaluated using average relative deviation (ARD), mean error and root mean squared error. In vitro model with constant flow rate could mimic one-compartment model, while the in vitro model with decreasing flow rate could simulate the linear mammillary model with multiple compartments. Zero-order model could be simulated using the in vitro model with elevating flow rate. In vitro PK model with gradually decreasing flow rate reproduced the two-compartment kinetics of levo-ornidazole quite well. The ARD was 0.925 % between in vitro PK parameters and in vivo values. Results suggest that various types of PK model could be simulated using flow rate modulation method without modifying the structure. The method provides uniform settings for the simulation of linear mammillary model and zero-order model based on in vitro one-compartment model, and brings convenience to the pharmacodynamic study.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25354895     DOI: 10.1007/s10928-014-9396-7

Source DB:  PubMed          Journal:  J Pharmacokinet Pharmacodyn        ISSN: 1567-567X            Impact factor:   2.745


  21 in total

Review 1.  Developments in PK/PD: optimising efficacy and prevention of resistance. A critical review of PK/PD in in vitro models.

Authors:  Alasdair MacGowan; Karen Bowker
Journal:  Int J Antimicrob Agents       Date:  2002-04       Impact factor: 5.283

2.  Evaluation of two in vitro pharmacodynamic simulation models: microfiltration versus centrifugation-filtration.

Authors:  L Alou; D Sevillano; J H Bugella; F Fuentes; M L Gómez-Lus; J Prieto
Journal:  Int J Antimicrob Agents       Date:  2001-05       Impact factor: 5.283

Review 3.  Pharmacokinetics and pharmacodynamics of antimicrobials.

Authors:  G L Drusano
Journal:  Clin Infect Dis       Date:  2007-07-15       Impact factor: 9.079

Review 4.  Combination therapy for Gram-negative bacteria: what is the evidence?

Authors:  Joumana G Kmeid; Mona M Youssef; Zeina A Kanafani; Souha S Kanj
Journal:  Expert Rev Anti Infect Ther       Date:  2013-10-30       Impact factor: 5.091

Review 5.  In vitro pharmacodynamic models to determine the effect of antibacterial drugs.

Authors:  Julia Gloede; Christian Scheerans; Hartmut Derendorf; Charlotte Kloft
Journal:  J Antimicrob Chemother       Date:  2009-12-21       Impact factor: 5.790

6.  Pharmacodynamics of gemifloxacin against Streptococcus pneumoniae in an in vitro pharmacokinetic model of infection.

Authors:  A P MacGowan; C A Rogers; H A Holt; M Wootton; K E Bowker
Journal:  Antimicrob Agents Chemother       Date:  2001-10       Impact factor: 5.191

7.  Killing of Pseudomonas aeruginosa during continuous and intermittent infusion of ceftazidime in an in vitro pharmacokinetic model.

Authors:  J W Mouton; J G den Hollander
Journal:  Antimicrob Agents Chemother       Date:  1994-05       Impact factor: 5.191

Review 8.  Clinical pharmacology of antimicrobial use in humans and animals.

Authors:  Claire M Lathers
Journal:  J Clin Pharmacol       Date:  2002-06       Impact factor: 3.126

9.  Pharmacokinetics of ceftazidime in patients with liver cirrhosis and ascites.

Authors:  M el Touny; M A el Guinaidy; M Abd el Barry; L Osman; M S Sabbour
Journal:  J Antimicrob Chemother       Date:  1991-07       Impact factor: 5.790

Review 10.  PK/PD models in antibacterial development.

Authors:  Tony Velkov; Phillip J Bergen; Jaime Lora-Tamayo; Cornelia B Landersdorfer; Jian Li
Journal:  Curr Opin Microbiol       Date:  2013-07-18       Impact factor: 7.934

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.